Answers (1)
Official Answer by Drugs.com
5 Jul 2017
Imfinzi (durvalumab) is a cancer medicine that works with your immune system to slow cancer cell growth. Imfinzi is classified as an anti-PD-L1 (programmed death ligand-1) human monoclonal antibody. In May 2017, Imfinzi was given FDA-approval for the treatment of patients with advanced urothelial carcinoma (bladder cancer) who have disease progression despite use of platinum-containing chemotherapy with or without surgery.
Further Information
- Imfinzi Information for Consumers
- Imfinzi Information for Healthcare Professionals (includes dosage details)
- Side Effects of Imfinzi (detailed)
Search for questions
Still looking for answers? Try searching for what you seek or ask your own question.
Frequently Asked Questions
How does the drug Lokelma work?
Posted 19 Jun 2018 • 1 answerFAQ by Drugs.com
How do you take Doptelet?
Posted 19 Jun 2018 • 1 answerFAQ by Drugs.com
What is the difference between Yonsa and Zytiga?
Posted 19 Jun 2018 • 1 answerFAQ by Drugs.com
Toujeo vs Lantus - What's the difference between them?
Posted 26 Jun 2018 • 1 answerFAQ by Drugs.com
Toujeo vs Tresiba - What's the difference between them?
Posted 29 Jun 2018 • 1 answerFAQ by Drugs.com
